Henry Schein Profit Margin 2006-2019 | HSIC

Current and historical gross margin, operating margin and net profit margin for Henry Schein (HSIC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Henry Schein net profit margin as of September 30, 2019 is 4.66%.
Henry Schein Annual Profit Margins
Henry Schein Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $10.050B $13.202B
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.678B 23.01
McKesson (MCK) United States $25.334B 10.04
Align Technology (ALGN) United States $20.969B 57.46
AmerisourceBergen (ABC) United States $17.472B 11.98
Laboratory Of America Holdings (LH) United States $16.176B 15.19
Cooper (COO) United States $15.711B 25.66
Cardinal Health (CAH) United States $15.695B 10.20
Straumann Holding AG (SAUHF) Switzerland $15.199B 0.00
DENTSPLY SIRONA (XRAY) United States $12.540B 24.51
West Pharmaceutical Services (WST) United States $10.830B 46.47
CONMED (CNMD) United States $3.146B 44.70
Patterson (PDCO) United States $1.992B 14.76
STAAR Surgical (STAA) United States $1.667B 87.05
Merit Medical Systems (MMSI) United States $1.644B 19.21
Atrion (ATRI) United States $1.306B 35.97
Antares Pharma (ATRS) United States $0.762B 467.00
Invacare (IVC) United States $0.313B 0.00
Lifevantage (LFVN) United States $0.220B 24.25
Pro-Dex (PDEX) United States $0.062B 16.82
Endologix (ELGX) United States $0.039B 0.00
Biolase (BIOL) United States $0.017B 0.00